Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,455
Closed -$1.02M 703
2026
Q1
$1.02M Sell
13,455
-2,751
-17% -$207K 0.02% 539
2025
Q4
$1.21M Buy
16,206
+6
+0% +$438 0.02% 548
2025
Q3
$1.09M Buy
16,200
+796
+5% +$52.8K 0.02% 560
2025
Q2
$1M Sell
15,404
-2,563
-14% -$154K 0.02% 547
2025
Q1
$1.11M Sell
17,967
-4,047
-18% -$268K 0.02% 517
2024
Q4
$1.59M Buy
22,014
+6,952
+46% +$543K 0.03% 462
2024
Q3
$1.23M Sell
15,062
-2,928
-16% -$234K 0.03% 455
2024
Q2
$1.34M Buy
+17,990
New +$1.35M 0.03% 448

Other funds holding HOLX

Mizuho Securities USA's HOLX Position: Q2 2026 in Review

Mizuho Securities USA sold out of Hologic (HOLX) in Q2 2026, closing a stake of 13,455 shares — an estimated $1.02M sold.

Mizuho Securities USA first reported a position in HOLX in Q2 2024 and held it in 8 quarters. The position peaked at $1.59M in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Mizuho Securities USA reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Mizuho Securities USA sold 13,455 Hologic shares in Q2 2026, an estimated $1.02M.
  • Mizuho Securities USA first reported a position in Hologic in Q2 2024 and held it in 8 quarters.
  • Mizuho Securities USA's Hologic position peaked at $1.59M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.